债务利息支出 更改
Alaunos Therapeutics USD 1.07M 215K 2023-06
Amgen USD 95.64B 94.98B 2026-06
AstraZeneca USD 340M 144M 2026-06
Bayer EUR 675M 87M 2025-12
Bristol-Myers Squibb USD 407M 4M 2026-06
CSL USD 215M 111M 2025-12
Curis USD 178K 441K 2023-12
Eli Lilly USD 114.7M 134.3M 2025-09
Exelixis USD 23.4M 3.9M 2023-09
Gilead Sciences USD 247M 7M 2026-06
GlaxoSmithKline GBP 121M 46M 2026-06
Incyte USD 582K 13K 2026-06
Merck USD 525M 46M 2026-06
Novartis USD 462M 119M 2026-06
Pfizer USD 667M 4M 2026-06
Roche Holding CHF 304M 7.5M 2025-06
Sanofi EUR 287M 109M 2026-06
Takeda JPY 63.85B 20.2B 2026-06
TG Therapeutics USD 16.57M 8.91M 2026-06
Verastem USD 382K 33K 2026-03